Company Name: |
Energy Chemical
|
Tel: |
021-58432009 400-005-6266 |
Email: |
marketing1@energy-chemical.com |
Products Intro: |
Product Name:(4S)-3-[(2R)-2-[(R)-[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]phenyl][(4-fluorophenyl)amino]methyl]-4-[2-(4-fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]-1-oxobutyl]-4-phenyl-2-oxazolidinone CAS:1478663-96-5 Purity:NULL Package:10mg;25mg;50mg;5mg Remarks:NULL
|
Company Name: |
QUALITY CONTROL SOLUTIONS LTD.
|
Tel: |
13670046396 |
Email: |
ORDERS@QCSRM.COM |
Products Intro: |
Product Name:Ezetimibe Impurity 113 Purity:95% HPLC Package:10MG;25MG;50MG;100MG
|
Company Name: |
Shenzhen Roark Pharma-Tec Co., Ltd.
|
Tel: |
13128912434 |
Email: |
2880126944@qq.com |
Products Intro: |
Product Name:Ezetimibe Impurity 19 CAS:1478663-96-5 Purity:99% HPLC Package:10MG;25MG;50MG;100MG
|
Company Name: |
HX Pharmaceutical technology co., LTD
|
Tel: |
15671363360 |
Email: |
494267389@qq.com |
Products Intro: |
Product Name:Ezetimibe Impurity 113 CAS:1478663-96-5 Purity:>95% HPLC Package:10mg;20mg;50mg;100mg
|
Company Name: |
Shanghai Zerui Biotechnology Co., Ltd.
|
Tel: |
021-54580889 18321124657 |
Email: |
731997554@qq.com |
Products Intro: |
Product Name:Ezetimibe Impurity 113 CAS:1478663-96-5 Purity:98% HPLC Package:10mg;25mg;50mg;100mg
|
|
| (4S)-3-[(2R)-2-[(R)-[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]phenyl][(4-fluorophenyl)amino]methyl]-4-[2-(4-fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]-1-oxobutyl]-4-phenyl-2-oxazolidinone Basic information |
| (4S)-3-[(2R)-2-[(R)-[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]phenyl][(4-fluorophenyl)amino]methyl]-4-[2-(4-fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]-1-oxobutyl]-4-phenyl-2-oxazolidinone Chemical Properties |
solubility | DCM, Ethyl Acetate | form | Solid | color | White |
| (4S)-3-[(2R)-2-[(R)-[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]phenyl][(4-fluorophenyl)amino]methyl]-4-[2-(4-fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]-1-oxobutyl]-4-phenyl-2-oxazolidinone Usage And Synthesis |
Uses | (4S)-3-[(2R)-2-[(R)-[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]phenyl][(4-fluorophenyl)amino]methyl]-4-[2-(4-fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]-1-oxobutyl]-4-phenyl-2-oxazolidinone is an intermediate in the synthesis of (3’R,3R,4R)-Ezetimibe (E974990), a structural analog of Ezetimibe (E975000). Ezetimibe is an antihyperlipoproteinemic and a cholesterol absorption inhibitor. |
| (4S)-3-[(2R)-2-[(R)-[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]phenyl][(4-fluorophenyl)amino]methyl]-4-[2-(4-fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]-1-oxobutyl]-4-phenyl-2-oxazolidinone Preparation Products And Raw materials |
|